July 01, 2025

The Optimism of Optogenetics

Several companies are sponsoring clinical development of optogenetic therapies, each with distinct approaches and technologies.

Ophthalmology Management

July 01, 2025

Getting YAG in the Bag: Tips for Success

Joe Munsell, OD, dedicated part of his 2025 Optometry’s Meeting lecture, “Optometric Laser Procedures: Pearls, Pitfalls, and How to Successfully Incorporate Into Your Practice,” to clinical pearls related to the procedure.

Optometric Management

July 01, 2025

Dr. Shannon Boye

Atsena Therapeutics’ founder and chief scientific officer discusses her role as CSO, the latest developments with ATSN-101, trends in the ocular gene therapy space, and more.

Ophthalmology Management

July 01, 2025

Director of Clinical Resources Group Announces Report on Ocular Risks of Glucagon-Like Peptide-1 Agonists

During the AOA’s 2025 House of Delegates meeting, director of the AOA’s clinical resources group, Andrew Morgenstern, OD, announced the report, “Glucagon-like Peptide-1 Receptor Agonists and Ocular Health: Guidance for Optometric Practice.”

Optometric Management

June 30, 2025

A Second Glance

An international research team challenges the main hypothesis regarding the evolution of human eye appearance

The Ophthalmologist

June 27, 2025

Also in the News…

The Ophthalmologist brings you the top news stories and studies of the week

The Ophthalmologist

June 24, 2025

“Shifting the Curve” with EYLEA 8 mg

Why Dr. David Brown of Retina Consultants of Texas advocates for 8 mg aflibercept for all eligible treatment-naïve patients

The Ophthalmologist

June 23, 2025

Risk of Diabetic Retinopathy Linked to Vitamin A Deficiency

New study reiterates the links between vitamin A deficiency and diabetic retinopathy risk and severity in type 2 diabetes mellitus patients

The Ophthalmologist

June 18, 2025

Cataract phacoemulsification

Gavin W. Roddy, M.D., Ph.D., is a glaucoma surgeon and a cataract specialist at Mayo Clinic in Rochester, Minnesota. In this video, he performs a cataract phacoemulsification on an 80-year-old woman who has had an increasingly difficult time driving.

Mayo Clinic